nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—XDH—Azathioprine—systemic scleroderma	0.711	1	CbGbCtD
Procarbazine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000346	0.0012	CcSEcCtD
Procarbazine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000344	0.00119	CcSEcCtD
Procarbazine—Cough—Lisinopril—systemic scleroderma	0.000343	0.00119	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00034	0.00118	CcSEcCtD
Procarbazine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00034	0.00118	CcSEcCtD
Procarbazine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000338	0.00117	CcSEcCtD
Procarbazine—Insomnia—Leflunomide—systemic scleroderma	0.000338	0.00117	CcSEcCtD
Procarbazine—Paraesthesia—Leflunomide—systemic scleroderma	0.000335	0.00116	CcSEcCtD
Procarbazine—Arthralgia—Lisinopril—systemic scleroderma	0.000335	0.00116	CcSEcCtD
Procarbazine—Myalgia—Lisinopril—systemic scleroderma	0.000335	0.00116	CcSEcCtD
Procarbazine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000335	0.00116	CcSEcCtD
Procarbazine—Anxiety—Lisinopril—systemic scleroderma	0.000334	0.00116	CcSEcCtD
Procarbazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000333	0.00115	CcSEcCtD
Procarbazine—Lethargy—Methotrexate—systemic scleroderma	0.000331	0.00115	CcSEcCtD
Procarbazine—Pancreatitis—Prednisone—systemic scleroderma	0.000329	0.00114	CcSEcCtD
Procarbazine—Vomiting—Mometasone—systemic scleroderma	0.000328	0.00114	CcSEcCtD
Procarbazine—Dry mouth—Lisinopril—systemic scleroderma	0.000327	0.00113	CcSEcCtD
Procarbazine—Sweating increased—Prednisone—systemic scleroderma	0.000326	0.00113	CcSEcCtD
Procarbazine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000326	0.00113	CcSEcCtD
Procarbazine—Rash—Mometasone—systemic scleroderma	0.000325	0.00113	CcSEcCtD
Procarbazine—Asthenia—Captopril—systemic scleroderma	0.000325	0.00113	CcSEcCtD
Procarbazine—Dermatitis—Mometasone—systemic scleroderma	0.000325	0.00113	CcSEcCtD
Procarbazine—Decreased appetite—Leflunomide—systemic scleroderma	0.000325	0.00112	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000325	0.00112	CcSEcCtD
Procarbazine—Confusional state—Lisinopril—systemic scleroderma	0.000324	0.00112	CcSEcCtD
Procarbazine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000323	0.00112	CcSEcCtD
Procarbazine—Headache—Mometasone—systemic scleroderma	0.000323	0.00112	CcSEcCtD
Procarbazine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000323	0.00112	CcSEcCtD
Procarbazine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000322	0.00112	CcSEcCtD
Procarbazine—Fatigue—Leflunomide—systemic scleroderma	0.000322	0.00112	CcSEcCtD
Procarbazine—Oedema—Lisinopril—systemic scleroderma	0.000321	0.00111	CcSEcCtD
Procarbazine—Pruritus—Captopril—systemic scleroderma	0.000321	0.00111	CcSEcCtD
Procarbazine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00032	0.00111	CcSEcCtD
Procarbazine—Pain—Leflunomide—systemic scleroderma	0.000319	0.00111	CcSEcCtD
Procarbazine—Constipation—Leflunomide—systemic scleroderma	0.000319	0.00111	CcSEcCtD
Procarbazine—Infection—Lisinopril—systemic scleroderma	0.000319	0.0011	CcSEcCtD
Procarbazine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.0011	CcSEcCtD
Procarbazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000317	0.0011	CcSEcCtD
Procarbazine—Shock—Lisinopril—systemic scleroderma	0.000316	0.00109	CcSEcCtD
Procarbazine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000314	0.00109	CcSEcCtD
Procarbazine—Tachycardia—Lisinopril—systemic scleroderma	0.000313	0.00108	CcSEcCtD
Procarbazine—Body temperature increased—Azathioprine—systemic scleroderma	0.000313	0.00108	CcSEcCtD
Procarbazine—Abdominal pain—Azathioprine—systemic scleroderma	0.000313	0.00108	CcSEcCtD
Procarbazine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00031	0.00107	CcSEcCtD
Procarbazine—Diarrhoea—Captopril—systemic scleroderma	0.00031	0.00107	CcSEcCtD
Procarbazine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00031	0.00107	CcSEcCtD
Procarbazine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00107	CcSEcCtD
Procarbazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00107	CcSEcCtD
Procarbazine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000308	0.00107	CcSEcCtD
Procarbazine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000307	0.00106	CcSEcCtD
Procarbazine—Nausea—Mometasone—systemic scleroderma	0.000306	0.00106	CcSEcCtD
Procarbazine—Anorexia—Lisinopril—systemic scleroderma	0.000306	0.00106	CcSEcCtD
Procarbazine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000305	0.00106	CcSEcCtD
Procarbazine—Ataxia—Methotrexate—systemic scleroderma	0.000305	0.00106	CcSEcCtD
Procarbazine—Pain—Mycophenolic acid—systemic scleroderma	0.000305	0.00106	CcSEcCtD
Procarbazine—Constipation—Mycophenolic acid—systemic scleroderma	0.000305	0.00106	CcSEcCtD
Procarbazine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00105	CcSEcCtD
Procarbazine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00104	CcSEcCtD
Procarbazine—Hypotension—Lisinopril—systemic scleroderma	0.0003	0.00104	CcSEcCtD
Procarbazine—Dizziness—Captopril—systemic scleroderma	0.0003	0.00104	CcSEcCtD
Procarbazine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00103	CcSEcCtD
Procarbazine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00103	CcSEcCtD
Procarbazine—Urticaria—Leflunomide—systemic scleroderma	0.000297	0.00103	CcSEcCtD
Procarbazine—Body temperature increased—Leflunomide—systemic scleroderma	0.000295	0.00102	CcSEcCtD
Procarbazine—Abdominal pain—Leflunomide—systemic scleroderma	0.000295	0.00102	CcSEcCtD
Procarbazine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000294	0.00102	CcSEcCtD
Procarbazine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00102	CcSEcCtD
Procarbazine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00102	CcSEcCtD
Procarbazine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000293	0.00101	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000292	0.00101	CcSEcCtD
Procarbazine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000292	0.00101	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000292	0.00101	CcSEcCtD
Procarbazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000291	0.00101	CcSEcCtD
Procarbazine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000291	0.00101	CcSEcCtD
Procarbazine—Insomnia—Lisinopril—systemic scleroderma	0.00029	0.00101	CcSEcCtD
Procarbazine—Paraesthesia—Lisinopril—systemic scleroderma	0.000288	0.000998	CcSEcCtD
Procarbazine—Vomiting—Captopril—systemic scleroderma	0.000288	0.000998	CcSEcCtD
Procarbazine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000994	CcSEcCtD
Procarbazine—Rash—Captopril—systemic scleroderma	0.000286	0.00099	CcSEcCtD
Procarbazine—Dermatitis—Captopril—systemic scleroderma	0.000285	0.000989	CcSEcCtD
Procarbazine—Somnolence—Lisinopril—systemic scleroderma	0.000285	0.000988	CcSEcCtD
Procarbazine—Headache—Captopril—systemic scleroderma	0.000284	0.000983	CcSEcCtD
Procarbazine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000982	CcSEcCtD
Procarbazine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000282	0.000976	CcSEcCtD
Procarbazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000282	0.000976	CcSEcCtD
Procarbazine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000974	CcSEcCtD
Procarbazine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000968	CcSEcCtD
Procarbazine—Decreased appetite—Lisinopril—systemic scleroderma	0.000279	0.000966	CcSEcCtD
Procarbazine—Eosinophilia—Methotrexate—systemic scleroderma	0.000277	0.000961	CcSEcCtD
Procarbazine—Fatigue—Lisinopril—systemic scleroderma	0.000277	0.000958	CcSEcCtD
Procarbazine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000958	CcSEcCtD
Procarbazine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000954	CcSEcCtD
Procarbazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000275	0.000953	CcSEcCtD
Procarbazine—Pancreatitis—Methotrexate—systemic scleroderma	0.000275	0.000951	CcSEcCtD
Procarbazine—Constipation—Lisinopril—systemic scleroderma	0.000274	0.000951	CcSEcCtD
Procarbazine—Pain—Lisinopril—systemic scleroderma	0.000274	0.000951	CcSEcCtD
Procarbazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000274	0.000951	CcSEcCtD
Procarbazine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000942	CcSEcCtD
Procarbazine—Diarrhoea—Azathioprine—systemic scleroderma	0.000271	0.000937	CcSEcCtD
Procarbazine—Haemoglobin—Prednisone—systemic scleroderma	0.00027	0.000934	CcSEcCtD
Procarbazine—Nausea—Captopril—systemic scleroderma	0.000269	0.000932	CcSEcCtD
Procarbazine—Haemorrhage—Prednisone—systemic scleroderma	0.000268	0.000929	CcSEcCtD
Procarbazine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000928	CcSEcCtD
Procarbazine—Asthenia—Leflunomide—systemic scleroderma	0.000268	0.000928	CcSEcCtD
Procarbazine—Hallucination—Prednisone—systemic scleroderma	0.000267	0.000925	CcSEcCtD
Procarbazine—Pancytopenia—Methotrexate—systemic scleroderma	0.000266	0.000921	CcSEcCtD
Procarbazine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000264	0.000916	CcSEcCtD
Procarbazine—Pruritus—Leflunomide—systemic scleroderma	0.000264	0.000915	CcSEcCtD
Procarbazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00091	CcSEcCtD
Procarbazine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000262	0.000909	CcSEcCtD
Procarbazine—Dizziness—Azathioprine—systemic scleroderma	0.000262	0.000906	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000887	CcSEcCtD
Procarbazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000256	0.000886	CcSEcCtD
Procarbazine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000256	0.000885	CcSEcCtD
Procarbazine—Diarrhoea—Leflunomide—systemic scleroderma	0.000256	0.000885	CcSEcCtD
Procarbazine—Urticaria—Lisinopril—systemic scleroderma	0.000255	0.000883	CcSEcCtD
Procarbazine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000881	CcSEcCtD
Procarbazine—Abdominal pain—Lisinopril—systemic scleroderma	0.000254	0.000879	CcSEcCtD
Procarbazine—Body temperature increased—Lisinopril—systemic scleroderma	0.000254	0.000879	CcSEcCtD
Procarbazine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000875	CcSEcCtD
Procarbazine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000252	0.000873	CcSEcCtD
Procarbazine—Vomiting—Azathioprine—systemic scleroderma	0.000251	0.000871	CcSEcCtD
Procarbazine—Pneumonia—Methotrexate—systemic scleroderma	0.000251	0.00087	CcSEcCtD
Procarbazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00025	0.000866	CcSEcCtD
Procarbazine—Drowsiness—Methotrexate—systemic scleroderma	0.00025	0.000865	CcSEcCtD
Procarbazine—Rash—Azathioprine—systemic scleroderma	0.000249	0.000864	CcSEcCtD
Procarbazine—Dermatitis—Azathioprine—systemic scleroderma	0.000249	0.000863	CcSEcCtD
Procarbazine—Flushing—Prednisone—systemic scleroderma	0.000249	0.000862	CcSEcCtD
Procarbazine—Headache—Azathioprine—systemic scleroderma	0.000248	0.000858	CcSEcCtD
Procarbazine—Dizziness—Leflunomide—systemic scleroderma	0.000247	0.000855	CcSEcCtD
Procarbazine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000847	CcSEcCtD
Procarbazine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000244	0.000844	CcSEcCtD
Procarbazine—Stomatitis—Methotrexate—systemic scleroderma	0.000243	0.000843	CcSEcCtD
Procarbazine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000833	CcSEcCtD
Procarbazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000833	CcSEcCtD
Procarbazine—Arrhythmia—Prednisone—systemic scleroderma	0.00024	0.00083	CcSEcCtD
Procarbazine—Sweating—Methotrexate—systemic scleroderma	0.000239	0.000829	CcSEcCtD
Procarbazine—Haematuria—Methotrexate—systemic scleroderma	0.000238	0.000825	CcSEcCtD
Procarbazine—Vomiting—Leflunomide—systemic scleroderma	0.000237	0.000823	CcSEcCtD
Procarbazine—Alopecia—Prednisone—systemic scleroderma	0.000237	0.000821	CcSEcCtD
Procarbazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000236	0.000819	CcSEcCtD
Procarbazine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000236	0.000816	CcSEcCtD
Procarbazine—Epistaxis—Methotrexate—systemic scleroderma	0.000236	0.000816	CcSEcCtD
Procarbazine—Rash—Leflunomide—systemic scleroderma	0.000235	0.000816	CcSEcCtD
Procarbazine—Dermatitis—Leflunomide—systemic scleroderma	0.000235	0.000815	CcSEcCtD
Procarbazine—Nausea—Azathioprine—systemic scleroderma	0.000235	0.000814	CcSEcCtD
Procarbazine—Headache—Leflunomide—systemic scleroderma	0.000234	0.00081	CcSEcCtD
Procarbazine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000803	CcSEcCtD
Procarbazine—Asthenia—Lisinopril—systemic scleroderma	0.00023	0.000798	CcSEcCtD
Procarbazine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000796	CcSEcCtD
Procarbazine—Pruritus—Lisinopril—systemic scleroderma	0.000227	0.000786	CcSEcCtD
Procarbazine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000227	0.000785	CcSEcCtD
Procarbazine—Haemoglobin—Methotrexate—systemic scleroderma	0.000225	0.000781	CcSEcCtD
Procarbazine—Rash—Mycophenolic acid—systemic scleroderma	0.000225	0.000778	CcSEcCtD
Procarbazine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000224	0.000777	CcSEcCtD
Procarbazine—Haemorrhage—Methotrexate—systemic scleroderma	0.000224	0.000777	CcSEcCtD
Procarbazine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000774	CcSEcCtD
Procarbazine—Headache—Mycophenolic acid—systemic scleroderma	0.000223	0.000773	CcSEcCtD
Procarbazine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00077	CcSEcCtD
Procarbazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00077	CcSEcCtD
Procarbazine—Nausea—Leflunomide—systemic scleroderma	0.000222	0.000768	CcSEcCtD
Procarbazine—Diarrhoea—Lisinopril—systemic scleroderma	0.00022	0.000761	CcSEcCtD
Procarbazine—Anaemia—Prednisone—systemic scleroderma	0.000216	0.000748	CcSEcCtD
Procarbazine—Dizziness—Lisinopril—systemic scleroderma	0.000212	0.000735	CcSEcCtD
Procarbazine—Nausea—Mycophenolic acid—systemic scleroderma	0.000212	0.000733	CcSEcCtD
Procarbazine—Syncope—Prednisone—systemic scleroderma	0.000209	0.000725	CcSEcCtD
Procarbazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000718	CcSEcCtD
Procarbazine—Loss of consciousness—Prednisone—systemic scleroderma	0.000205	0.000711	CcSEcCtD
Procarbazine—Vomiting—Lisinopril—systemic scleroderma	0.000204	0.000707	CcSEcCtD
Procarbazine—Rash—Lisinopril—systemic scleroderma	0.000202	0.000701	CcSEcCtD
Procarbazine—Convulsion—Prednisone—systemic scleroderma	0.000202	0.000701	CcSEcCtD
Procarbazine—Dermatitis—Lisinopril—systemic scleroderma	0.000202	0.0007	CcSEcCtD
Procarbazine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000699	CcSEcCtD
Procarbazine—Hypertension—Prednisone—systemic scleroderma	0.000202	0.000698	CcSEcCtD
Procarbazine—Chills—Methotrexate—systemic scleroderma	0.000201	0.000697	CcSEcCtD
Procarbazine—Headache—Lisinopril—systemic scleroderma	0.000201	0.000696	CcSEcCtD
Procarbazine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000689	CcSEcCtD
Procarbazine—Arthralgia—Prednisone—systemic scleroderma	0.000199	0.000689	CcSEcCtD
Procarbazine—Myalgia—Prednisone—systemic scleroderma	0.000199	0.000689	CcSEcCtD
Procarbazine—Anxiety—Prednisone—systemic scleroderma	0.000198	0.000686	CcSEcCtD
Procarbazine—Alopecia—Methotrexate—systemic scleroderma	0.000198	0.000686	CcSEcCtD
Procarbazine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000666	CcSEcCtD
Procarbazine—Nausea—Lisinopril—systemic scleroderma	0.000191	0.00066	CcSEcCtD
Procarbazine—Oedema—Prednisone—systemic scleroderma	0.000191	0.00066	CcSEcCtD
Procarbazine—Infection—Prednisone—systemic scleroderma	0.000189	0.000656	CcSEcCtD
Procarbazine—Shock—Prednisone—systemic scleroderma	0.000188	0.00065	CcSEcCtD
Procarbazine—Tachycardia—Prednisone—systemic scleroderma	0.000186	0.000644	CcSEcCtD
Procarbazine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000644	CcSEcCtD
Procarbazine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000184	0.000638	CcSEcCtD
Procarbazine—Anorexia—Prednisone—systemic scleroderma	0.000182	0.000629	CcSEcCtD
Procarbazine—Anaemia—Methotrexate—systemic scleroderma	0.00018	0.000625	CcSEcCtD
Procarbazine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000619	CcSEcCtD
Procarbazine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000614	CcSEcCtD
Procarbazine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000614	CcSEcCtD
Procarbazine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00061	CcSEcCtD
Procarbazine—Leukopenia—Methotrexate—systemic scleroderma	0.000175	0.000605	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000174	0.000602	CcSEcCtD
Procarbazine—Insomnia—Prednisone—systemic scleroderma	0.000172	0.000597	CcSEcCtD
Procarbazine—Paraesthesia—Prednisone—systemic scleroderma	0.000171	0.000593	CcSEcCtD
Procarbazine—Cough—Methotrexate—systemic scleroderma	0.00017	0.00059	CcSEcCtD
Procarbazine—Convulsion—Methotrexate—systemic scleroderma	0.000169	0.000586	CcSEcCtD
Procarbazine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000579	CcSEcCtD
Procarbazine—Arthralgia—Methotrexate—systemic scleroderma	0.000166	0.000576	CcSEcCtD
Procarbazine—Myalgia—Methotrexate—systemic scleroderma	0.000166	0.000576	CcSEcCtD
Procarbazine—Decreased appetite—Prednisone—systemic scleroderma	0.000166	0.000574	CcSEcCtD
Procarbazine—Fatigue—Prednisone—systemic scleroderma	0.000164	0.000569	CcSEcCtD
Procarbazine—Constipation—Prednisone—systemic scleroderma	0.000163	0.000565	CcSEcCtD
Procarbazine—Confusional state—Methotrexate—systemic scleroderma	0.000161	0.000556	CcSEcCtD
Procarbazine—Infection—Methotrexate—systemic scleroderma	0.000158	0.000548	CcSEcCtD
Procarbazine—Feeling abnormal—Prednisone—systemic scleroderma	0.000157	0.000544	CcSEcCtD
Procarbazine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000156	0.00054	CcSEcCtD
Procarbazine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000156	0.00054	CcSEcCtD
Procarbazine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000154	0.000533	CcSEcCtD
Procarbazine—Anorexia—Methotrexate—systemic scleroderma	0.000152	0.000526	CcSEcCtD
Procarbazine—Urticaria—Prednisone—systemic scleroderma	0.000151	0.000524	CcSEcCtD
Procarbazine—Body temperature increased—Prednisone—systemic scleroderma	0.000151	0.000522	CcSEcCtD
Procarbazine—Abdominal pain—Prednisone—systemic scleroderma	0.000151	0.000522	CcSEcCtD
Procarbazine—Hypotension—Methotrexate—systemic scleroderma	0.000149	0.000516	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000145	0.000503	CcSEcCtD
Procarbazine—Insomnia—Methotrexate—systemic scleroderma	0.000144	0.000499	CcSEcCtD
Procarbazine—Paraesthesia—Methotrexate—systemic scleroderma	0.000143	0.000495	CcSEcCtD
Procarbazine—Somnolence—Methotrexate—systemic scleroderma	0.000142	0.000491	CcSEcCtD
Procarbazine—Hypersensitivity—Prednisone—systemic scleroderma	0.00014	0.000486	CcSEcCtD
Procarbazine—Decreased appetite—Methotrexate—systemic scleroderma	0.000138	0.00048	CcSEcCtD
Procarbazine—Fatigue—Methotrexate—systemic scleroderma	0.000137	0.000476	CcSEcCtD
Procarbazine—Asthenia—Prednisone—systemic scleroderma	0.000137	0.000474	CcSEcCtD
Procarbazine—Pain—Methotrexate—systemic scleroderma	0.000136	0.000472	CcSEcCtD
Procarbazine—Pruritus—Prednisone—systemic scleroderma	0.000135	0.000467	CcSEcCtD
Procarbazine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000131	0.000455	CcSEcCtD
Procarbazine—Diarrhoea—Prednisone—systemic scleroderma	0.00013	0.000452	CcSEcCtD
Procarbazine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00013	0.000451	CcSEcCtD
Procarbazine—Urticaria—Methotrexate—systemic scleroderma	0.000127	0.000438	CcSEcCtD
Procarbazine—Dizziness—Prednisone—systemic scleroderma	0.000126	0.000437	CcSEcCtD
Procarbazine—Abdominal pain—Methotrexate—systemic scleroderma	0.000126	0.000436	CcSEcCtD
Procarbazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000126	0.000436	CcSEcCtD
Procarbazine—Vomiting—Prednisone—systemic scleroderma	0.000121	0.00042	CcSEcCtD
Procarbazine—Rash—Prednisone—systemic scleroderma	0.00012	0.000416	CcSEcCtD
Procarbazine—Dermatitis—Prednisone—systemic scleroderma	0.00012	0.000416	CcSEcCtD
Procarbazine—Headache—Prednisone—systemic scleroderma	0.000119	0.000414	CcSEcCtD
Procarbazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000117	0.000407	CcSEcCtD
Procarbazine—Asthenia—Methotrexate—systemic scleroderma	0.000114	0.000396	CcSEcCtD
Procarbazine—Nausea—Prednisone—systemic scleroderma	0.000113	0.000392	CcSEcCtD
Procarbazine—Pruritus—Methotrexate—systemic scleroderma	0.000113	0.00039	CcSEcCtD
Procarbazine—Diarrhoea—Methotrexate—systemic scleroderma	0.000109	0.000378	CcSEcCtD
Procarbazine—Dizziness—Methotrexate—systemic scleroderma	0.000105	0.000365	CcSEcCtD
Procarbazine—Vomiting—Methotrexate—systemic scleroderma	0.000101	0.000351	CcSEcCtD
Procarbazine—Rash—Methotrexate—systemic scleroderma	0.0001	0.000348	CcSEcCtD
Procarbazine—Dermatitis—Methotrexate—systemic scleroderma	0.0001	0.000348	CcSEcCtD
Procarbazine—Headache—Methotrexate—systemic scleroderma	9.98e-05	0.000346	CcSEcCtD
Procarbazine—Nausea—Methotrexate—systemic scleroderma	9.46e-05	0.000328	CcSEcCtD
